Research Article
Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
Table 1
Clinical characteristics of patients stratified by chronic liver disease status.
| | Liver disease () | No liver disease () | value |
| Age | 61.5 (51.0-67.0) | 71.0 (54.0-82.0) | 0.13 | Sex | | | Male | 4 (28.6) | 72 (38.5) | 0.57 | Female | 10 (71.4) | 115 (61.5) | Immunosuppression | | | No | 11/14 (78.6%) | 160/187 (85.6%) | 0.44 | Yes | 3/14 (21.4%) | 27/187 (14.4%) | Inflammatory bowel disease | | | No | 12/14 (85.7%) | 169/187 (90.4%) | 0.64 | Yes | 2/14 (14.3%) | 18/187 (9.6%) | Recent antibiotic exposure | | | No | 11/14 (78.6%) | 78/187 (41.7%) | 0.01 | Yes | 3/14 (21.4%) | 109/187 (58.3) | Route of fecal microbiota transplantation delivery | | | Colonoscopy | 5/14 (35.7%) | 40/187 (21.4%) | 0.76 | Enema | 2/14 (14.3%) | 73/187 (39.0%) | Nasogastric tube | 7/14 (50.0%) | 69/187 (36.9%) | Percutaneous endoscopic gastrostomy | 0/14 (0.0%) | 5/187 (2.7%) | Recent hospitalization | | | No | 9/14 (64.3%) | 99/187 (52.9%) | 0.58 |
|
|